Helen Atkins Selected Research

3- (4- chlorophenyl)- 3- (4- hydroxy- 3,5- dimethoxybenzyloxy)- 2- propyl- 2,3- dihydroisoindol- 1- one

10/2006	Small-molecule inhibitors of the MDM2-p53 protein-protein interaction based on an isoindolinone scaffold.
3/2005	Isoindolinone-based inhibitors of the MDM2-p53 protein-protein interaction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Helen Atkins Research Topics

Disease

2	Sarcoma (Soft Tissue Sarcoma) 10/2006 - 03/2005
1	Dental Caries (Decay, Dental) 10/2020
1	Neoplasms (Cancer) 09/2007

Drug/Important Bio-Agent (IBA)

2	3- (4- chlorophenyl)- 3- (4- hydroxy- 3,5- dimethoxybenzyloxy)- 2- propyl- 2,3- dihydroisoindol- 1- oneIBA 10/2006 - 03/2005
1	AntibodiesIBA 09/2007
1	RNA (Ribonucleic Acid)IBA 09/2007
1	Proto-Oncogene Proteins c-mdm2IBA 09/2007
1	2- benzyl- 3- (4- chlorophenyl)- 3- (3- hydroxypropoxy)- 2,3- dihydroisoindol- 1- oneIBA 10/2006

Therapy/Procedure

1	Fluoridation 10/2020